PETS Petmed Express Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: PETS

Price (delayed)

$1.56

Market cap

$33.82M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.38

Enterprise value

$21.15M

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 17

Founded in 1996, PetMeds is Your Trusted Pet Health Expert™, delivering prescription and non-prescription pet medications and other health products for dogs, cats, and horses at competitive prices direct to ...

Highlights
PETS's debt has dropped by 53% year-on-year and by 23% since the previous quarter
Petmed Express's EPS has increased by 50% QoQ and by 35% YoY
The equity has dropped by 55% year-on-year and by 21% since the previous quarter
The quick ratio has plunged by 51% YoY and by 20% from the previous quarter
Sector: Healthcare
Industry: Pharmaceutical Retailers
Website: http://www.1800petmeds.com
Peers: CVS XNCR

Key stats

What are the main financial stats of PETS

PETS stock price

How has the Petmed Express stock price performed over time
Intraday
0.65%
1 week
-3.7%
1 month
-10.86%
1 year
-40.91%
YTD
-51.25%
QTD
-18.75%

Financial performance

How have Petmed Express's revenue and profit performed over time
Revenue
$168.86M
Gross profit
$47.15M
Operating income
-$30.77M
Net income
-$29.28M
Gross margin
27.9%
Net margin
-17.3%
The company's net income rose by 49% QoQ and by 34% YoY
The operating income is up by 48% from the previous quarter and by 23% YoY
PETS's net margin is up by 46% since the previous quarter and by 17% year-on-year
The company's operating margin rose by 45% QoQ and by 3.7% YoY

Price vs fundamentals

How does PETS's price correlate with its fundamentals

Growth

What is Petmed Express's growth rate over time

Valuation

What is Petmed Express stock price valuation
PETS P/E details
P/E
N/A
P/B
1.45
P/S
0.2
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.13
Petmed Express's EPS has increased by 50% QoQ and by 35% YoY
The equity has dropped by 55% year-on-year and by 21% since the previous quarter
The price to book (P/B) is 31% lower than the 5-year quarterly average of 2.1 and 15% lower than the last 4 quarters average of 1.7
The P/S is 78% below the 5-year quarterly average of 0.9 and 33% below the last 4 quarters average of 0.3
The revenue has contracted by 20% YoY and by 6% from the previous quarter

Efficiency

How efficient is Petmed Express business performance
PETS's ROE has plunged by 71% YoY but it is up by 37% from the previous quarter
Petmed Express's return on sales has increased by 46% QoQ and by 5% YoY
The company's return on assets rose by 42% QoQ but it fell by 9% YoY

Dividends

What is PETS's dividend history
Dividend details
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
Dividend history

Special dividends are included in TTM DPS and yield

Financial health

How did Petmed Express financials performed over time
Petmed Express's total assets is 56% more than its total liabilities
The quick ratio has plunged by 51% YoY and by 20% from the previous quarter
The current ratio has contracted by 42% YoY and by 19% from the previous quarter
PETS's debt is 98% smaller than its equity
The equity has dropped by 55% year-on-year and by 21% since the previous quarter
PETS's debt has dropped by 53% year-on-year and by 23% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.